Postprandial hyperlipidemia as a coronary atherosclerosis factor in patients with metabolic syndrome; corrective potential of rosuvastatin therapy
Aim. To investigate the atherogenic role of postprandial hyperlipidemia (PPH) and endothelial dysfunction (ED) in the development of coronary angiosclerosis in patients with coronary heart disease (CHD) and metabolic syndrome (MS); to study the effectiveness of rosuvastatin in the correction of thes...
Saved in:
Main Authors: | , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
1970-01-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/2176 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|